MESENCHYMAL STROMAL CELLS (MSCs) Amnion Tissue

MESENCHYMAL STROMAL CELLS (MSCs) Amnion Tissue

Amniotic mesenchymal stromal cells are seen in amniotic membranes and fluid. In ongoing clinical trials, amniotic mesenchymal stromal cells demonstrate great therapeutic potential that holds great promise in the future of regenerative medicine especially for various degenerative and inflammatory conditions without current treatment options.


Properties of Amniotic Mesenchymal Stromal Cells
Amniotic MSCs can differentiate to bone, cartilage, heart, fat, muscle, nerve, liver, pancreas, blood vessel, immune system populations and skin among some of the directions they can take and repairing all organs and tissues in our body.

- On top of that in numerous recent clinical trials, their immense expansion potential has been elucidated.
- These cells can produce cytokines that can modulate inflammation and the immune system.
- In similarity to other MSC, these cells can avoid immune detection as they do not yet present HLA antigens used in adult immune systems to detect foreign cells.


Benefits of MSCs: Amnion Tissue
Due to their vast expansion potential, these cells demonstrate potential in conditions related to almost all organ systems.

Respiratory System : Idiopathic Pulmonary Fibrosis
Gastrointestinal System : Crohn's Disease
Nervous System : Multiple Sclerosis (MS), Neuronal Regenerative Therapy
Hematopoietic and Immunological Systems : Graft Versus Host Disease
Musculoskeletal System-Orthopedic Surgery : Osteoarthritis
Skin Conditions : Skin Tissue Engineering, Photoaging

"Amniotic MSCs therapy will be a promising answer for many of today's untreatable diseases in the years to come"

Reference: Srivastava M et al. 2018